These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 103421)

  • 1. Coronary arterial responses to graded doses of nitroglycerin.
    Feldman RL; Pepine CJ; Curry RC; Conti CR
    Am J Cardiol; 1979 Jan; 43(1):91-7. PubMed ID: 103421
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of intracoronary nitroglycerin to alleviate pacing-induced angina.
    Ganz W; Marcus HS
    Circulation; 1972 Nov; 46(5):880-9. PubMed ID: 4628189
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of sublingually and intravenously administered nitroglycerin on the cardiovascular system of the dog.
    Gillis RA; Melville KI
    Am J Cardiol; 1971 Jul; 28(1):38-42. PubMed ID: 4997142
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustained effects of nitroglycerin ointment in patients with angina pectoris.
    Reichek N; Goldstein RE; Redwood DR; Epstein SE
    Circulation; 1974 Aug; 50(2):348-52. PubMed ID: 4211087
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cutaneous nitroglycerin patches on coronary artery diameter: issues concerning development of tolerance.
    Moreyra AE; Kostis JB
    J Am Coll Cardiol; 1989 Feb; 13(2):428-33. PubMed ID: 2492324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual vasomotor coronary arterial responses after nitroglycerin.
    Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 Sep; 42(3):517-9. PubMed ID: 99020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic variations in resistance of coronary arterial narrowings in angina pectoris at rest.
    Ganz P; Abben RP; Barry WH
    Am J Cardiol; 1987 Jan; 59(1):66-70. PubMed ID: 3101476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences of intravenous nitroglycerin responses in left ventricular systolic and end-diastolic pressures and coronary artery diameters during long-term treatment with cutaneous nitroglycerin patches.
    Naito H; Matsuda Y; Yorozu T; Maeda T; Tada T; Shiomi K
    Clin Cardiol; 1993 Feb; 16(2):123-7. PubMed ID: 8435925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable responses of highly stenotic coronary arteries and collateral circulation to intracoronary injection of nitroglycerin in patients with chronic effort angina.
    Fujita M; Yamanishi K; Miwa K; Inoko M
    Coron Artery Dis; 1994 Jun; 5(6):525-9. PubMed ID: 7952412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action and clinical use of nitroglycerin.
    Horwitz LD
    Postgrad Med; 1973 Apr; 53(4):167-9. PubMed ID: 4632992
    [No Abstract]   [Full Text] [Related]  

  • 11. Action and nomenclature of nitroglycerin and nitrate esters.
    Krantz JC
    Am J Cardiol; 1972 Mar; 29(3):436-8. PubMed ID: 4621891
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris].
    Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507
    [No Abstract]   [Full Text] [Related]  

  • 13. Captopril potentiates the effects of nitroglycerin in the coronary vascular bed.
    Meredith IT; Alison JF; Zhang FM; Horowitz JD; Harper RW
    J Am Coll Cardiol; 1993 Aug; 22(2):581-7. PubMed ID: 8335833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary arterial spasm in classic angina pectoris.
    Chahine RA; Raizner AE; Luchi RJ
    Cathet Cardiovasc Diagn; 1975; 1(3):337-42. PubMed ID: 816469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-anginal efficacy of oral nitroglycerin. A clinical double-blind study with dose-effect relationships].
    Schneider W; Kaltenbach M; Stahl B; Bussmann WD
    Dtsch Med Wochenschr; 1984 Aug; 109(31-32):1187-91. PubMed ID: 6430666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic approach to the treatment of angina pectoris.
    Mason DT; Spann JF; Zelis R; Amsterdam EA
    N Engl J Med; 1969 Nov; 281(22):1225-8. PubMed ID: 4981526
    [No Abstract]   [Full Text] [Related]  

  • 17. Left ventricular function during spontaneous angina pectoris: effect of sublingual nitroglycerin.
    Sharma B; Hodges M; Asinger RW; Goodwin JF; Francis GS
    Am J Cardiol; 1980 Jul; 46(1):34-41. PubMed ID: 6770669
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of action of nitroglycerin. Stenosis vasodilation as a major component of the drug response.
    Dodge HT; Brown BG
    Scand J Clin Lab Invest Suppl; 1984; 173():41-5. PubMed ID: 6442001
    [No Abstract]   [Full Text] [Related]  

  • 19. Different effects of nitroglycerin and nitroprusside on myocardial blood flow and metabolism.
    Ihlen H
    Scand J Clin Lab Invest Suppl; 1984; 173():75-9. PubMed ID: 6442005
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of lidoflazine as an anti-anginal drug.
    Vohra JK; Sloman JG
    Cardiology; 1973; 58(4):209-19. PubMed ID: 4206284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.